Impact Biomedical: NYSE American stock removal notice
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
25-NSE
Rhea-AI Filing Summary
IMPACT BIOMEDICAL INC. (IBO)'s common stock is the subject of a notice concerning removal from listing and/or registration on NYSE American LLC. The notice states that the issuer complied with requirements governing voluntary withdrawal.
Key Terms
voluntary withdrawal
1 terms
voluntary withdrawal regulatory
"governing the voluntary withdrawal of the class of securities from listing and registration"
AI-generated analysis. How Rhea-AI works. Not financial advice.